Contractor
WE PHARMA, INC.
- UEI
- EWAMVJSFNK29
- Parent UEI
- EWAMVJSFNK29
- Resolved by
- uei
- Confidence
- 1.000
Active from May 6, 2026 to Jul 24, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75F40123F19003 DEOBLIGATION/CLOSEOUT | Department of Health and Human Services | MD | Jul 24, 2026 | $213,614 |
| 75F40121D00018 THE CONTRACTOR SHALL PROVIDE THE FDA WITH THE FOLLOWING: I. PRODUCTS LISTED IN ATTACHMENT 1 (PHARMACEUTICAL PRICING LIST), IN RESPONSE TO GOVERNMENT ORDERS. AT A MINIMUM, THIS TABLE WILL BE UPDATED ONCE A YEAR. II. SUPPLY EMERGENCY OVERNIGHT DELI | Department of Health and Human Services | — | May 27, 2026 | — |
| 75F40125F19004 TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Department of Health and Human Services | MD | May 6, 2026 | $1,507,060 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier EWAMVJSFNK29, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.